Parameters influencing the stealthiness of colloidal drug delivery systems.

By A. Vonarbourg, C. Passirani, P. Saulnier, J. Benoit. Biomaterials, 2006

712 citations recorded by the source corpus.

Subfields: Molecular Biology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/b1b8d3b21caa7890a20468de880a74ad8b92a125

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Pharmaceutical Science

Citations in the corpus

Pharmacokinetic aspects of retinal drug delivery. (2017, positive): “This defence mechanism has been partly overcome with coated particles that have reduced protein adherence and slowed removal from the blood circulation (Illum and Davis, 1984; Owens and Peppas, 2006; Vonarbourg et al., 2006).”
Immunological properties of engineered nanomaterials (2007, methodology): “Surface modifications with PEG, poloxamer and poloxamine polymers have been used as particle 'camouflage' to prevent phagocytosi”
Understanding biophysicochemical interactions at the nano-bio interface. (2009, background): “Examples are attachment of polymers (PEG, carboxymethyl cellulose), electrostatic repulsion (such as attachment of surfactants) or electrosteric repulsion (such as attachment of anionic triblock copolymers or poly(aspartic acid)”
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity (2012, background): “Surface modification of nanomaterials with hydrophilic polymers such as polyethylene glycol, polyethylene oxide, and poloxamers can significantly reduce the opsonization of nanoparticles by serum proteins [14,15].”
Nanocarriers’ entry into the cell: relevance to drug delivery (2009, background): “Poly(ethyleneglycol) [PEG, also known as poly(oxoethylene)] has been extensively described for this purpose [6, 7].”
The journey of a drug-carrier in the body: an anatomo-physiological perspective. (2012, background): “It is not the objective of this review to cover surface modification strategies, (see refs, [33,35,67,68] for more information on this topic) but PEGylation still remains today the gold standard to impart CDCs with long circulation times [69,70].”